Format

Send to

Choose Destination
Anticancer Agents Med Chem. 2012 Jan;12(1):4-18.

Impact of oncogenic protein tyrosine phosphatases in cancer.

Author information

1
Goodman Research Cancer Centre, McGill University, 1160 Pine Avenue, Room 601 Montreal, QC, Canada H3A 1A3.

Abstract

Protein tyrosine phosphatases (PTPs) constitute a large family of enzymes that can exert both positive and negative effects on signaling pathways. They play dominant roles in setting the levels of intracellular phosphorylation downstream of many receptors including receptor tyrosine kinases and G protein-coupled receptors. As observed with kinases, deregulation of PTP activity can also contribute to cancer. This review will examine a broad array of PTP family members that positively affect oncogenesis in human cancer tissues. We will describe the PTP family, their biological significance in oncology, and how recent progress is being made to more effectively target specific PTPs. Finally, we will discuss the therapeutic implications of targeting these oncogenic PTPs in cancer.

PMID:
21707506
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Bentham Science Publishers Ltd.
Loading ...
Support Center